Magazine article from our research archive:
|
|
Clinical highlights: hyperviscosity syndrome in patients with multiple myeloma.(CLINICAL CHALLENGES)(Disease/Disorder overview)
- Article from:
-
Oncology Nursing Forum
- Article date:
-
May 1, 2008
|
Copyright informationCOPYRIGHT 2008 Oncology Nursing Society. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Definition
Hyperviscosity syndrome is the term used to describe the clinical signs and symptoms related to increased blood viscosity. Hyperviscosity is defined on the basis of the relative viscosity of blood compared to water (Park et al., 2005), with normal serum viscosity level 1.8 centipoise (cp).
Incidence
Approximately 50,000 Americans have multiple myeloma, with 19,900 new diagnoses in 2007 (Jemal et al., 2007). The disease is more common in men than women, and more common in African Americans than other ethnic groups. Hyperviscosity syndrome is a rare complication of multiple myeloma that occurs in about 2%-6% of patients, most frequently in immunoglobulin ...
|
Multiple Myeloma: Recognition and Management.
American Family Physician;
April 1, 1999 ;
George, Enitza D. Sadovsky, Richard;
787 words
......Science Center, Brooklyn, New York Multiple myeloma is the malignant proliferation of...10 percent of the bone marrow. The multiple myeloma cell produces monoclonal immunoglobulins...fracture, commonly of the axial skeleton. Multiple myeloma must be differentiated from other...
|
 "Stamford Advocate (Stamford, CT)")
|
Multiple myeloma foundation cheered by new therapy.
Stamford Advocate (Stamford, CT);
July 11, 2006 ;
476 words
......Richard Lee Jul. 11--The Norwalk-based Multiple Myeloma Research Foundation is reveling in...treatment for relapsed or refractory multiple myeloma by the U.S. Food and Drug Administration...step forward for the treatment of multiple myeloma, said Kathy Giusti, founder and chief...
|
|
ABO discrepancy in a multiple myeloma patients: A case study
Clinical Laboratory Science;
October 1, 2002 ;
Wilson, Jo Ann; Jacobs, Angel;
787 words
......are expected to die of multiple myeloma in 2001.5,6 Etiology and epidemiology The etiology of multiple myeloma is unknown; however, genetics...Increases in the incidence of multiple myeloma during this past century...increased incidence of multiple myeloma. Studies of ...
|
|
The Multiple Myeloma Research Foundation Goes into the Dugouts to Help...
PR Newswire;
June 16, 2004 ;
562 words
......share a passion to find a cure for multiple myeloma, a deadly form of blood cancer...accompany Kathy Giusti, president of the Multiple Myeloma Research Foundation (MMRF), to throw...pitch to show support for thousands of multiple myeloma patients and to kick- off the MMRF...
|
|
|
Millennium Initiates Phase II Clinical Trials of LDP-341 in Multiple...
PR Newswire;
March 1, 2001 ;
787 words
......trial of LDP-341 (formerly PS-341) for multiple myeloma has been initiated. LDP-341 is an...safety and efficacy in patients with multiple myeloma who have relapsed following front...additional Phase II clinical trial in multiple myeloma is scheduled to begin in the second...
|
|
|
The Multiple Myeloma Research Foundation is Available to Provide...
PR Newswire;
April 12, 2000 ;
787 words
...Recently Diagnosed with Multiple Myeloma, New York Yankee Mel Stottlemyer...Stottlemyer was diagnosed with multiple myeloma, a form of blood cancer. This...curiosity among the public about multiple myeloma. The Multiple Myeloma Research...
|
|
Multiple myeloma
Rehabilitation Oncology;
January 1, 2003 ;
Poulson, Bo; Gudas, Stephen A;
787 words
...INTRODUCTION Multiple myeloma is a cancer caused by malignant...risks that are associated with multiple myeloma, although nothing strictly predisposes the disease. The number of multiple myeloma cases is increasing due to the...
|
|
|
Annual Multiple Myeloma Research Foundation (MMRF) Chicago Awards Dinner...
PR Newswire;
April 5, 2006 ;
596 words
......Conn., April 5 /PRNewswire/ -- The Multiple Myeloma Research Foundation (MMRF) last night...mission of accelerating a cure for multiple myeloma, the second most common blood cancer...and effective treatment options for multiple myeloma. Sayers and Hunt joined Corporate...
|
|
|
Clinical Data on ACTIMID(TM) in Multiple Myeloma to be Presented at the...
PR Newswire;
December 4, 2003 ;
787 words
......on-going clinical trials of ACTIMID in multiple myeloma and its mechanism of action at the...ACTIMID in oral or poster sessions: Multiple Myeloma: * An Update of the Use and Outcomes...Patients with Relapsed Refractory Multiple Myeloma (Poster Session); Abstract #1640...
|
See all results.
Or, try our
Advanced Search.
|